UY24401A1 - PROCEDURES AND INTERMEDIATES TO PREPARE 1-BENZYL-4- ((5,6-DIMETOXI-1-INDANON) -2-IL) METHYLPIPERIDINE. - Google Patents

PROCEDURES AND INTERMEDIATES TO PREPARE 1-BENZYL-4- ((5,6-DIMETOXI-1-INDANON) -2-IL) METHYLPIPERIDINE.

Info

Publication number
UY24401A1
UY24401A1 UY24401A UY24401A UY24401A1 UY 24401 A1 UY24401 A1 UY 24401A1 UY 24401 A UY24401 A UY 24401A UY 24401 A UY24401 A UY 24401A UY 24401 A1 UY24401 A1 UY 24401A1
Authority
UY
Uruguay
Prior art keywords
indanon
methylpiperidine
benzyl
dimetoxi
intermediates
Prior art date
Application number
UY24401A
Other languages
Spanish (es)
Inventor
M Devries Keith
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of UY24401A1 publication Critical patent/UY24401A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Esta invención se refiere a un nuevo procedimiento para preparar 1-bencil-4-((5,6-dimetoxi-1-indanon)-2-il)-metilpiperidina y a nuevos intermedios usados en dicho procedimiento. Un compuesto de fórmula l, ll, lll en la que R1 es R2O(C=O). Un procedimiento en el que dicho agente de metenilación es tetrametildiaminometano en anhidrico acético. Es útil para el tratamiento, prevención, mejoría, etc de diversos tipos de demencia senil, en particular Alzheimer.This invention relates to a new process for preparing 1-benzyl-4 - ((5,6-dimethoxy-1-indanon) -2-yl) -methylpiperidine and to new intermediates used in said process. A compound of formula l, ll, lll wherein R1 is R2O (C = O). A process wherein said methenylating agent is tetramethyldiaminomethane in acetic anhydrous. It is useful for the treatment, prevention, improvement, etc. of various types of senile dementia, in particular Alzheimer's.

UY24401A 1995-12-15 1996-12-12 PROCEDURES AND INTERMEDIATES TO PREPARE 1-BENZYL-4- ((5,6-DIMETOXI-1-INDANON) -2-IL) METHYLPIPERIDINE. UY24401A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US875395P 1995-12-15 1995-12-15

Publications (1)

Publication Number Publication Date
UY24401A1 true UY24401A1 (en) 1997-06-09

Family

ID=21733469

Family Applications (1)

Application Number Title Priority Date Filing Date
UY24401A UY24401A1 (en) 1995-12-15 1996-12-12 PROCEDURES AND INTERMEDIATES TO PREPARE 1-BENZYL-4- ((5,6-DIMETOXI-1-INDANON) -2-IL) METHYLPIPERIDINE.

Country Status (33)

Country Link
EP (1) EP0883607A1 (en)
JP (1) JP3066083B2 (en)
KR (1) KR20000064387A (en)
AP (1) AP708A (en)
AR (1) AR004368A1 (en)
AU (1) AU716462B2 (en)
BG (1) BG102525A (en)
BR (1) BR9612018A (en)
CA (1) CA2237647A1 (en)
CO (1) CO4750831A1 (en)
CZ (1) CZ180898A3 (en)
DZ (1) DZ2141A1 (en)
GT (1) GT199600092A (en)
HN (1) HN1996000065A (en)
HR (1) HRP960592A2 (en)
HU (1) HUP9904275A3 (en)
IL (3) IL136421A0 (en)
IS (1) IS4752A (en)
MA (1) MA24032A1 (en)
NO (1) NO982712L (en)
NZ (1) NZ318843A (en)
OA (1) OA10694A (en)
PE (1) PE25698A1 (en)
PL (1) PL197306B1 (en)
RO (1) RO121382B1 (en)
RU (1) RU2160731C2 (en)
SK (1) SK75498A3 (en)
TN (1) TNSN96153A1 (en)
TW (1) TW414787B (en)
UY (1) UY24401A1 (en)
WO (1) WO1997022584A1 (en)
YU (1) YU49486B (en)
ZA (1) ZA9610533B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999036405A1 (en) 1998-01-16 1999-07-22 Eisai Co., Ltd. Process for production of donepezil derivative
IL125809A (en) * 1998-08-17 2005-08-31 Finetech Lab Ltd Process and intermediates for production of donepezil and related compounds
US7148354B2 (en) * 2002-07-24 2006-12-12 Dr. Reddy's Laboratories Limited Process for preparation of donepezil
IL150982A (en) 2002-07-30 2007-02-11 Ori Lerman Process for the preparation of donepezil
IL151253A0 (en) * 2002-08-14 2003-04-10 Finetech Lab Ltd Process for production of highly pure donepezil hydrochloride
US6953856B2 (en) 2003-02-12 2005-10-11 Usv, Limited Process for the preparation of 1-benzyl-4-(5,6-dimethoxy-1-indanon)-2-yl) methyl piperidine hydrochloride (Donepezil HCI)
US6649765B1 (en) 2003-02-12 2003-11-18 Usv Limited, Bsd Marg. Process for the preparation of 1-benzyl-4(5,6-dimethoxy-1-indanon)-2-yl) methyl piperidine hydrochloride (Donepezil HCL)
EP1608371A1 (en) * 2003-03-21 2005-12-28 Ranbaxy Laboratories, Ltd. Process for the preparation of donepezil and derivatives thereof
WO2004099142A1 (en) * 2003-05-05 2004-11-18 Ranbaxy Laboratories Limited Hydrobromide salt of benzyl-piperidylmethyl-indanone and its polymorphs
AU2003247158A1 (en) 2003-07-01 2005-01-21 Hetero Drugs Limited Preparation of intermediates for acetyl cholinesterase inhibitors
CN1280273C (en) 2003-11-05 2006-10-18 天津和美生物技术有限公司 Synthesis of donepizin and its derivative
JP2008514691A (en) 2004-09-29 2008-05-08 ケマジス リミティド Use of purified donepezil maleate to produce pharmaceutically pure amorphous donepezil hydrochloride
CN100436416C (en) * 2005-07-29 2008-11-26 西南合成制药股份有限公司 Novel donepezil synthesis process
GB0515803D0 (en) 2005-07-30 2005-09-07 Pliva Hrvatska D O O Intermediate compounds
AR057910A1 (en) 2005-11-18 2007-12-26 Synthon Bv PROCESS TO PREPARE DONEPEZILO
ES2354737T3 (en) 2006-01-04 2011-03-17 Cipla Limited PROCEDURE AND INTERMEDIATE PRODUCT FOR THE PREPARATION OF DONEPEZYLO.
BRPI0720211A2 (en) * 2006-12-11 2013-12-24 Reviva Pharmaceuticals Inc INDANONE DERIVATIVE, COMPOSITION, AND, USE OF A COMPOSITION
WO2013078608A1 (en) * 2011-11-29 2013-06-06 Ziqiang Gu Donepezil pamoate and methods of making and using the same
AU2014307803A1 (en) 2013-08-16 2016-03-10 Universiteit Maastricht Treatment of cognitive impairment with PDE4 inhibitor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI95572C (en) * 1987-06-22 1996-02-26 Eisai Co Ltd Process for the preparation of a medicament useful as a piperidine derivative or its pharmaceutical salt
FR2642069B1 (en) * 1989-01-20 1991-04-12 Rhone Poulenc Sante NOVEL BENZOPYRAN DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DE4439822A1 (en) * 1994-11-08 1996-08-29 Bayer Ag Process for the preparation of benzyl-piperidylmethyl-indanones

Also Published As

Publication number Publication date
PL327512A1 (en) 1998-12-21
AU716462B2 (en) 2000-02-24
DZ2141A1 (en) 2002-07-23
PL197306B1 (en) 2008-03-31
RU2160731C2 (en) 2000-12-20
MX9804820A (en) 1998-10-31
NO982712D0 (en) 1998-06-12
OA10694A (en) 2001-05-04
EP0883607A1 (en) 1998-12-16
PE25698A1 (en) 1998-05-21
AP708A (en) 1998-12-04
GT199600092A (en) 1998-05-12
NO982712L (en) 1998-06-12
RO121382B1 (en) 2007-04-30
AR004368A1 (en) 1998-11-04
HRP960592A2 (en) 1998-06-30
ZA9610533B (en) 1998-06-15
AU7092596A (en) 1997-07-14
JPH11500756A (en) 1999-01-19
NZ318843A (en) 2000-01-28
YU49486B (en) 2006-08-17
BR9612018A (en) 1999-02-17
TW414787B (en) 2000-12-11
HUP9904275A2 (en) 2000-05-28
SK75498A3 (en) 1999-08-06
MA24032A1 (en) 1997-07-01
YU66096A (en) 1999-11-22
BG102525A (en) 1999-05-31
KR20000064387A (en) 2000-11-06
CA2237647A1 (en) 1997-06-26
TNSN96153A1 (en) 2005-03-15
AP9600892A0 (en) 1997-01-31
IL124452A0 (en) 1998-12-06
IS4752A (en) 1998-05-22
WO1997022584A1 (en) 1997-06-26
HN1996000065A (en) 1997-06-26
IL136420A0 (en) 2001-06-14
CZ180898A3 (en) 1999-05-12
HUP9904275A3 (en) 2001-05-28
JP3066083B2 (en) 2000-07-17
CO4750831A1 (en) 1999-03-31
IL136421A0 (en) 2001-06-14

Similar Documents

Publication Publication Date Title
UY24401A1 (en) PROCEDURES AND INTERMEDIATES TO PREPARE 1-BENZYL-4- ((5,6-DIMETOXI-1-INDANON) -2-IL) METHYLPIPERIDINE.
FI20000353A (en) Preparation of 3,4,4-trisubstituted piperidinyl N-alkylcarboxylate and intermediates
DE69531624D1 (en) METHOD FOR PRODUCING LEVOBUPIVACAINE AND ANALOG
DE69532565D1 (en) Process for the preparation of isoguanosine and 2'-derivatives thereof
CA2585705A1 (en) Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
ZA893104B (en) Novel benzopyrido piperidine,piperidylidene and piperazine compounds,compositions,methods of manufacture and methods of use
ES2112669T3 (en) USE OF HYDROXYLATED CARBOXYLIC ACIDS FOR THE TREATMENT OF NAILS
ATE214695T1 (en) RACEMIZATION PROCESS IN THE PRODUCTION OF LEVOBUPIVACAINE AND ANALOGUES
HUP9900927A3 (en) Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
DE69523038D1 (en) METHOD FOR PRODUCING HIV PROTEASINHIBITORS
HUP0000756A2 (en) Use of levobupivacaine or ropivacaine for producing pharmaceutical compositions suitable for treating migraine
NO20002450L (en) Composition of active ingredients, in particular tetrahydropyridines and acetylcholinesterase inhibitors, for the treatment of senile dementia of Alzheimer's type
DE69811893D1 (en) METHOD FOR PRODUCING AZETIDINE-2-CARBONIC ACID AND INTERMEDIATE PRODUCTS THEREOF
NO941134L (en) 1,2,5,6-tetrahydropyridine derivative, process for its preparation, and its therapeutic uses
NO993078L (en) Process for the preparation of tetrahydropyridine derivative
ZA969484B (en) Novel substituted 4-(1H-benzimidazol-2-yl-amino)- piperidines useful for the treatment of allergic diseases
ES2117934A1 (en) Alkylazole tetrahydropyridines (or 4-hydroxypiperidines)

Legal Events

Date Code Title Description
VENC Patent expired

Effective date: 20161212